Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 3
1977 6
1978 10
1979 6
1980 10
1981 6
1982 10
1983 7
1984 5
1985 15
1986 1
1987 6
1988 11
1989 21
1990 24
1991 14
1992 24
1993 23
1994 21
1995 26
1996 15
1997 12
1998 12
1999 7
2000 11
2001 18
2002 12
2003 13
2004 7
2005 11
2006 9
2007 15
2008 16
2009 17
2010 17
2011 12
2012 4
2013 8
2014 5
2015 1
2016 1
2017 4
2018 1
2019 1
2020 1
2021 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

469 results

Results by year

Filters applied: . Clear all
Page 1
Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group. Fassnacht M, et al. N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551107 Free article. Clinical Trial.
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Sternberg CN, et al. Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11. Lancet Oncol. 2015. PMID: 25498218 Free article. Clinical Trial.
Advanced testis cancer.
Droz JP, Rivoire M. Droz JP, et al. Curr Treat Options Oncol. 2001 Oct;2(5):421-9. doi: 10.1007/s11864-001-0047-z. Curr Treat Options Oncol. 2001. PMID: 12057105 Review.
[Overview of infectious and non-infectious diseases in French Guiana in 2022].
Epelboin L, Abboud P, Abdelmoumen K, About F, Adenis A, Blaise T, Blaizot R, Bonifay T, Bourne-Watrin M, Boutrou M, Carles G, Carlier PY, Carod JF, Carvalho L, Couppié P, De Toffol B, Delon F, Demar M, Destoop J, Douine M, Droz JP, Elenga N, Enfissi A, Franck YK, Fremery A, Gaillet M, Kallel H, Kpangon AA, Lavergne A, Le Turnier P, Maisonobe L, Michaud C, Mutricy R, Nacher M, Naldjinan-Kodbaye R, Oberlis M, Odonne G, Osei L, Pujo J, Rabier S, Roman-Laverdure B, Rousseau C, Rousset D, Sabbah N, Sainte-Rose V, Schaub R, Sylla K, Tareau MA, Tertre V, Thorey C, Vialette V, Walter G, Zappa M, Djossou F, Vignier N. Epelboin L, et al. Among authors: droz jp. Med Trop Sante Int. 2023 Feb 17;3(1):mtsi.v3i1.2023.308. doi: 10.48327/mtsi.v3i1.2023.308. eCollection 2023 Mar 31. Med Trop Sante Int. 2023. PMID: 37389381 Free PMC article. Review. French.
[Uncommon bladder tumours].
Boyle H, Fléchon A, Droz JP. Boyle H, et al. Among authors: droz jp. Bull Cancer. 2010;97 Suppl Cancer de la vessie:51-7. doi: 10.1684/bdc.2010.1097. Bull Cancer. 2010. PMID: 20534390 French.
The burden of rare cancers in Europe.
Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group. Gatta G, et al. Adv Exp Med Biol. 2010;686:285-303. doi: 10.1007/978-90-481-9485-8_17. Adv Exp Med Biol. 2010. PMID: 20824452 Review.
Potential drug interactions in elderly cancer patients.
Girre V, Arkoub H, Puts MT, Vantelon C, Blanchard F, Droz JP, Mignot L. Girre V, et al. Among authors: droz jp. Crit Rev Oncol Hematol. 2011 Jun;78(3):220-6. doi: 10.1016/j.critrevonc.2010.05.004. Epub 2010 Jul 1. Crit Rev Oncol Hematol. 2011. PMID: 20594867 Review.
Paraneoplastic glomerular diseases and malignancies.
Bacchetta J, Juillard L, Cochat P, Droz JP. Bacchetta J, et al. Among authors: droz jp. Crit Rev Oncol Hematol. 2009 Apr;70(1):39-58. doi: 10.1016/j.critrevonc.2008.08.003. Epub 2008 Sep 14. Crit Rev Oncol Hematol. 2009. PMID: 18790651 Review.
High-dose chemotherapy in germ-cell tumors.
Droz JP, Culine S, Biron P, Kramar A. Droz JP, et al. Ann Oncol. 1996 Dec;7(10):997-1003. doi: 10.1093/oxfordjournals.annonc.a010523. Ann Oncol. 1996. PMID: 9037356 Free article. Review.
469 results